Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Local Tobramycin Injection for Open Fracture Infection
NCT04964947Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2022
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tobramycin in Wound infection (WI), surgical site infection (SSI), sponsored by Massachusetts General Hospital. Started Jan 2022; status: completed.
02
Drugs
tobramycin
03
Conditions
Wound infection (WI)surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04964947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04964947.